Author:
Cosgrove Jason,Lyne Anne-Marie,Rodriguez Ildefonso,Cabeli Vincent,Conrad Cecile,Tenreira-Bento Sabrina,Tubeuf Emilie,Russo Erica,Tabarin Fanny,Belloucif Yannis,Maleki-Toyserkani Shayda,Reed Sophie,Monaco Federica,Ager Ann,Lobry Camille,Bousso Philippe,Fernández-Marcos Pablo Jose,Isambert Herve,Argüello Rafael J.,Perié Leïla
Abstract
SUMMARYFollowing infection, hematopoietic stem and progenitor cells (HSPCs) support immunity by increasing the rate of innate immune cell production but the metabolic cues that guide this process are unknown. To address this question, we developed MetaFate, a method to trace the metabolic expression state and developmental fate of single cellsin vivo. Using MetaFate we identified a gene expression program of metabolic enzymes and transporters that confers differences in myeloid differentiation potential in a subset of HSPCs that express CD62L. Using single-cell metabolic profiling, we confirmed that CD62Lhighmyeloid-biased HSPCs have an increased dependency on oxidative phosphorylation and glucose metabolism. Importantly, metabolism actively regulates immune-cell production, with overexpression of the glucose-6-phosphate dehydrogenase enzyme of the pentose phosphate pathway skewing MPP output from B-lymphocytes towards the myeloid lineages, and expansion of CD62LhighHSPCs occurring to support emergency myelopoiesis. Collectively, our data reveal the metabolic cues that instruct innate immune cell development, highlighting a key role for the pentose phosphate pathway. More broadly, our results show that HSPC metabolism can be manipulated to alter the cellular composition of the immune system.
Publisher
Cold Spring Harbor Laboratory
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献